Conciseness

The body is dense and tabular with no filler explanations of concepts Claude already knows; the CIViC gene ID table and gene alias normalization are genuinely non-obvious data. Minor trimmable padding remains (10-item KEY PRINCIPLES list, 8 example 'When to Use' queries), so it is efficient but not perfectly lean.

Actionability

Concrete, copy-paste-ready guidance throughout: exact scoring point tables (e.g., 'Exact variant match=40, Gene-level=30'), a report file naming pattern, a 10-section output structure, and specific tool pitfalls ('civic_search_variants/civic_search_evidence_items do NOT filter by query. Use civic_get_variants_by_gene with gene ID'). The actual tool-call syntax lives in references/phases_detail.md rather than inline, leaving minor gaps.

Workflow Clarity

The 11 phases (0-10) are clearly sequenced in a table with per-phase summaries, a Phase 0 parameter-verification checkpoint before any calls, and edge-case recovery strategies ('No matching trials - Broaden to gene-level -> pathway-level -> basket trials'). Not 5 because no explicit inline validate->fix->retry feedback loop is shown; not 3 because checkpoints and error recovery are explicitly present.

Progressive Disclosure

The body is a clean overview that appropriately splits detail into three one-level-deep references (phases_detail.md, scoring_and_matching.md, parsing_and_validation.md), each clearly signaled with blockquote pointers and summarized in a closing References table. All three files exist and match their described contents.

Specificity

Names concrete actions ('discovers and ranks clinical trials from ClinicalTrials.gov using multi-dimensional matching across molecular eligibility') plus explicit inputs (disease, molecular alterations, stage, prior treatments). Not 5 because 'AI-driven' and 'multi-dimensional matching' lean toward buzzword territory and the text is truncated ('...molecular eligibility...'), leaving coverage unclear; not 3 because it goes beyond 1-2 generic actions with a specific data source and input spec.

Completeness

Has a clear 'what' (discovers and ranks clinical trials from ClinicalTrials.gov given a patient profile) but no explicit 'Use when...' clause; 'Given a patient profile...' only weakly implies when to use it, and the truncation may have cut off trigger guidance. Per the rubric guideline, a missing explicit trigger clause caps completeness at 3.

Trigger Term Quality

Good natural keyword coverage: 'patient-to-trial matching', 'clinical trials', 'ClinicalTrials.gov', 'precision medicine', 'oncology', 'molecular alterations' are all phrases users would naturally say. A few natural synonyms are missing (e.g., 'biomarker', 'cancer trials', 'trial eligibility'), keeping it below the comprehensive 5 anchor.

Distinctiveness Conflict Risk

'AI-driven patient-to-trial matching for precision medicine and oncology... from ClinicalTrials.gov... molecular eligibility' carves out a clear niche with distinct triggers; virtually no other skill type would match a patient-to-trial matching request. Conflict risk is minimal.